Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class ASSE: 688621

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4327

· Issued by Beijing Sun-novo Pharmaceutical Research Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4327

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis